Monday, May 19, 2014

InterMune to resubmit lead drug for US approval after trial success

Retweeted Medical News (@MedicalNews): InterMune to resubmit lead drug for US approval after trial success http://t.co/5ERPZXPGmN

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/5ERPZXPGmN
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)